Due to limited experimental conditions, we plan to knock out or knock down SRXN1 expression in PC3 and DU145 cells and verify whether tumour cell sensitivity to radiotherapy will be increased after inhibiting SRXN1 expression. This evidence concerns the gene SRXN1 and neoplasm.